The consistency across both trials significantly strengthens the case for FDA approval
Enrolling 17,604 adults aged 45 or older with established cardiovascular disease and a BMI of 27 or higher (without diabetes), SELECT showed that semaglutide 2.4 mg reduced the composite of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke by 20% over a mean follow-up of nearly 40 months
Glutathione Injections: Side Effects & Benefits
These include: Fatigue, weakness, and pallor are the most common symptoms that appear in the early stages
Recognition sequence of a highly conserved DNA binding protein RBP-Jx
The 2019 approval, detailed in a 2020 drug review in the Annals of Pharmacotherapy , represented one of the first times the FDA had formally addressed female sexual desire as a clinical target